SYRE Shares Outstanding History Table | ||||||
Also see: SYRE Market Cap History SYRE YTD Return |
SYRE Shares Outstanding History Table | ||||||
Also see: SYRE Market Cap History SYRE YTD Return |
SYRE Shares Outstanding History Chart | |||||||
+2630.83% CAGR Mouse over chart for data details
|
SYRE Stock Price Chart |
About Spyre Therapeutics Inc |
Aeglea BioTherapeutics is a holding company. Through its subsidiaries, Co. is a biotechnology company developing human enzyme therapeutics for people with rare metabolic diseases. Co.'s development programs include: Pegzilarginase in Arginase 1 Deficiency, which is a recombinant human Arginase 1 that enzymatically degrades the amino acid arginine and improves the stability and arginine-degrading activity of the enzyme in human plasma; and AGLE-177 in Homocystinuria, which is a PEGylated, or polyethylene glycol modified, human enzyme engineered to degrade free homocysteine and homocystine. Co.'s preclinical pipeline includes cystinuria program to reduce plasma cystine and cysteine levels. We show 2 historical shares outstanding datapoints in our coverage of SYRE's shares outstanding history. Understanding the changing numbers of SYRE shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like SYRE versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching SYRE by allowing them to research SYRE shares outstanding history as well as any other stock in our coverage universe. |
SYRE Current Stock Quote |
Free SYRE Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Video: Shares Outstanding Importance | |
|
SYRE Share Performance |
Shares Outstanding Peers |
Spyre Therapeutics (SYRE) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
SYRS Shares Outstanding History |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.